logo

For the Inventor, By the Inventor

Minneapolis, MN, United States of America

Bio-Techne Corporation


USPTO Granted Patents = 12


Trademarks = 14

Forward Citations = 34

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Christine Goetz (4 out of 4 patents)

silverMedal Jody Bonnevier (4 out of 4 patents)

bronzeMedal Christopher Carlin Valley (4 out of 4 patents)

4.  Zhengliang L Wu (3 out of 7 patents)

5.  Birte Aggeler (3 out of 3 patents)

6.  Vassilios Kalabokis (3 out of 3 patents)

7.  Christopher Hammerbeck (3 out of 3 patents)

8.  Ernesto Ruben Resnik (2 out of 2 patents)

9.  Guoping Wu (2 out of 2 patents)

10.  Jinghua Wang (2 out of 2 patents)

11.  Jose Fernando Bazan (2 out of 2 patents)

12.  Anthony Person (1 out of 15 patents)

13.  Richard Karl Fuerstenberg (1 out of 1 patent)

14.  Joy Lynn Aho (1 out of 1 patent)

15.  Fabrizio Rinaldi (1 out of 2 patents)


12 patents:

1. 12704517 - ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES (2026-08-11),
2. 11897958 - Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using (2024-02-13),
3. 11787857 - Compounds that modulate the interaction of VISTA and VSIG3 and methods of making and using (2023-10-17),
4. 11649285 - Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy (2023-05-16),
5. 11524985 - IL-37 fusion protein and methods of making and using same (2022-12-13),
6. 11105796 - Methods for non-invasive profiling of stem cell differentiation (2021-08-31),
7. 11046738 - Wnt/sFRP complexes, Wnt-containing compositions, Wnt-expressing cells, and methods of making, purifying, and using same (2021-06-29),
8. 10890586 - Methods and kits for assaying endoglycosidase activity (2021-01-12),
9. 10752689 - Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using (2020-08-25),
10. 10640276 - Dual chamber storage device (2020-05-05),
11. 9410183 - Methods and kits for detection of O-GlcNAc and N-GlcNAc modification of peptides and proteins (2016-08-09),
12. 9410182 - Phosphatase coupled glycosyltransferase assay (2016-08-09),
Company Overview
Bio-Techne Corporation is a leading provider of life science reagents and instruments, specializing in the development and manufacturing of high-quality products for research and clinical applications. The company focuses on areas such as protein analysis, cellular analysis, and molecular biology, catering to the needs of researchers in academia and industry. Headquartered in Minneapolis, MN, Bio-Techne serves a global market, driving innovation in biotechnology and advancing scientific discovery through its diverse portfolio of solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Bio-Techne Corporation USPTO Patent Assignee Logo
12 Patents

#143 in Minneapolis, MN

#735 in Minnesota

#25,578 in US

#48,209 in the World

Minneapolis, MN (US)
Minneapolis, MN, United States of America

Bio-Techne Corporation

Forward Citations = 34

30 inventors:

goldMedal Christine Goetz (4 out of 4 patents)

silverMedal Jody Bonnevier (4 out of 4 patents)

bronzeMedal Christopher Carlin Valley (4 out of 4 patents)

4.  Zhengliang L Wu (3 out of 7 patents)

5.  Birte Aggeler (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bio-Techne Corporation. Retrieved from https://idiyas.com/company/bio-techne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…